Investment to progress RheumaGen’s celiac disease program through early development as a potential transformational gene therapy AURORA, Colo., Dec. 22, 2025 /PRNewswire/ — RheumaGen, Inc., a cell and gene therapy company engineering a new class of therapeutics to cure common autoimmune…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
BOULDER, Colo., June 21, 2022 /PRNewswire/ — Accure Acne, Inc. announced today that Samuel E. Navarro has joined Accure Acne’s Board of Directors. Along with Chairman and Founder Christopher Carlton, Founder Ed Barbera, and Board […]
Demand for the new class of weight-loss drugs has sent plan costs soaring. Click here to view original postClick Here to Publish/Feature Your Company or Product News with Biotech Networks
Walmart employees will have access to Kindbody’s network of facilities, including in Denver. Click here to view original post
Copyright © 2026 Biotech Networks
